{"id":1036950,"date":"2017-06-08T23:46:47","date_gmt":"2017-06-09T03:46:47","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/uncategorized\/ishares-nasdaq-biotechnology-index-ibb-shares-sold-by-neumann-capital-management-llc-the-cerbat-gem.php"},"modified":"2024-08-17T16:01:14","modified_gmt":"2024-08-17T20:01:14","slug":"ishares-nasdaq-biotechnology-index-ibb-shares-sold-by-neumann-capital-management-llc-the-cerbat-gem","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/ishares-nasdaq-biotechnology-index-ibb-shares-sold-by-neumann-capital-management-llc-the-cerbat-gem.php","title":{"rendered":"iShares NASDAQ Biotechnology Index (IBB) Shares Sold by Neumann Capital Management LLC &#8211; The Cerbat Gem"},"content":{"rendered":"<table border=\"0\" cellpadding=\"2\" cellspacing=\"7\" style=\"vertical-align:top;\"><tr><td width=\"80\" align=\"center\" valign=\"top\"><font style=\"font-size:85%;font-family:arial,sans-serif\"><\/font><\/td><td valign=\"top\" class=\"j\"><font style=\"font-size:85%;font-family:arial,sans-serif\"><div style=\"padding-top:0.8em;\"><img alt=\"\" height=\"1\" width=\"1\" style=\"padding-left:10px; padding-right: 10px;\"><\/div><div class=\"lh\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNH9mz3OUOssEHZIWVlSQAHL5xKcXQ&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779523484006&amp;ei=ERo6WdDnNsHVzAKuvqygBA&amp;url=https:\/\/www.thecerbatgem.com\/2017\/06\/08\/neumann-capital-management-llc-has-438000-stake-in-ishares-nasdaq-biotechnology-index-ibb-updated.html\"><b>iShares NASDAQ <b>Biotechnology<\/b> Index (IBB) Shares Sold by Neumann Capital Management LLC<\/b><\/a><br><font size=\"-1\"><b><font color=\"#6f6f6f\">The Cerbat Gem<\/font><\/b><\/font><br><font size=\"-1\">iShares NASDAQ <b>Biotechnology<\/b> Index logo Neumann Capital Management LLC decreased its position in iShares NASDAQ <b>Biotechnology<\/b> Index (NASDAQ:IBB) by 44.8% during the first quarter, according to its most recent 13F filing with the Securities and&nbsp;...<\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNG9rRpmKZTlYmFzl0EyjF-FG1fifg&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779523484006&amp;ei=ERo6WdDnNsHVzAKuvqygBA&amp;url=https:\/\/sportsperspectives.com\/2017\/06\/08\/vetr-inc-lowers-ishares-nasdaq-biotechnology-index-ibb-to-hold.html\">Vetr Inc. Lowers iShares NASDAQ Biotechnology Index (IBB) to Hold<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>Sports Perspectives<\/nobr><\/font><\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNGj0gYKiJFfB5xDyQGSnvQqs-2p5Q&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779523484006&amp;ei=ERo6WdDnNsHVzAKuvqygBA&amp;url=https:\/\/www.thestockobserver.com\/2017\/06\/08\/ishares-nasdaq-biotechnology-index-ibb-shares-bought-by-private-management-group-inc-updated.html\">Private Management Group Inc. Raises Stake in iShares NASDAQ <b>Biotechnology<\/b> Index (IBB)<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>Stock Observer<\/nobr><\/font><\/font><br><font size=\"-1\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNFT2B1ZPDXt1fVrkIX3-KchRpeJNA&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779523484006&amp;ei=ERo6WdDnNsHVzAKuvqygBA&amp;url=https:\/\/transcriptdaily.com\/2017\/06\/08\/bellevue-group-ag-has-3-52-million-stake-in-ishares-nasdaq-biotechnology-index-ibb.html\">Bellevue Group AG Has $3.52 Million Stake in iShares NASDAQ <b>Biotechnology<\/b> Index (IBB)<\/a><font size=\"-1\" color=\"#6f6f6f\"><nobr>Transcript Daily<\/nobr><\/font><\/font><br><font size=\"-1\" class=\"p\"><a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNG2TD-RYuj9pZbdXUdDBCa1oJLoCQ&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779523484006&amp;ei=ERo6WdDnNsHVzAKuvqygBA&amp;url=https:\/\/www.themarketsdaily.com\/2017\/06\/08\/ishares-nasdaq-biotechnology-index-ibb-position-lowered-by-lgl-partners-llc-updated.html\"><nobr>Markets Daily<\/nobr><\/a>&nbsp;-<a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNFOvOGhloZj-bOE-YLh0TMDXn4LrA&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779523484006&amp;ei=ERo6WdDnNsHVzAKuvqygBA&amp;url=https:\/\/baseballnewssource.com\/markets\/nn-investment-partners-holdings-n-v-has-914000-stake-in-ishares-nasdaq-biotechnology-index-ibb-updated\/872797.html\"><nobr>BBNS<\/nobr><\/a>&nbsp;-<a href=\"http:\/\/news.google.com\/news\/url?sa=t&amp;fd=R&amp;ct2=us&amp;usg=AFQjCNG9p4bxgGr18azR35PJHqNjHbHbhQ&amp;clid=c3a7d30bb8a4878e06b80cf16b898331&amp;cid=52779523484006&amp;ei=ERo6WdDnNsHVzAKuvqygBA&amp;url=http:\/\/bangaloreweekly.com\/investment-house-llc-buys-1056-shares-of-ishares-nasdaq-biotechnology-index-ibb-379192.html\"><nobr>BangaloreWeekly<\/nobr><\/a><\/font><br><font class=\"p\" size=\"-1\"><a class=\"p\" href=\"http:\/\/news.google.com\/news\/more?ncl=dGwzTiNPUTo5VXMCnRLbj0McLwMKM&amp;authuser=0&amp;ned=us\"><nobr><b>all 19 news articles&nbsp;&raquo;<\/b><\/nobr><\/a><\/font><\/div><p><\/p><\/font><\/td><\/tr><\/table><p><!-- Auto Generated --><\/p><p>Continue reading here:<br><a target=\"_blank\" href=\"https:\/\/www.thecerbatgem.com\/2017\/06\/08\/neumann-capital-management-llc-has-438000-stake-in-ishares-nasdaq-biotechnology-index-ibb-updated.html\" title=\"iShares NASDAQ Biotechnology Index (IBB) Shares Sold by Neumann Capital Management LLC - The Cerbat Gem\" rel=\"noopener\">iShares NASDAQ Biotechnology Index (IBB) Shares Sold by Neumann Capital Management LLC - The Cerbat Gem<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p> iShares NASDAQ Biotechnology Index (IBB) Shares Sold by Neumann Capital Management LLC The Cerbat Gem iShares NASDAQ Biotechnology Index logo Neumann Capital Management LLC decreased its position in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 44.8% during the first quarter, according to its most recent 13F filing with the Securities and&nbsp;... Vetr Inc.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/ishares-nasdaq-biotechnology-index-ibb-shares-sold-by-neumann-capital-management-llc-the-cerbat-gem.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-1036950","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036950"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1036950"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1036950\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1036950"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1036950"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1036950"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}